🇺🇸 FDA

Intelligence Platform

Patents

Browse 12 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10927136

Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators

Cyclerion Therapeutics, Inc. · Granted Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10421952

Mutant organophosphorus acid anhydrolase enzymes having increased catalytic efficiency on

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10335465

Mutant OPAA enzyme with increased catalytic efficiency on organophosphorus compound GP

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10260054

Engineered organophosphorus acid anhydrolases and methods of use thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10124043

Mutant OPAA enzymes with increased catalytic efficiency on organophosphorus compound EA135

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9976130

OPAA FL—a mutant enzyme with increased catalytic efficiency on organophosphorus compound G

The United States of America as represented by the Secretary of the Army · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9617526

Mutated organophosphorus acid anhydrolases and their uses thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9587232

Mutated organophosphorus acid anhydrolases and their uses thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9017982

Non-wild-type organophosphorus acid anhydrolases for enzymatic decontamination

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7951390

Slow-release microcapsule composition for safe delivery of agriculturally active material

United Phosphorus Limited · Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582605

Phosphorus-containing hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7229949

Safe delivery system for agriculturally active material

United Phosphorus Limited · Granted Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted